The briefing
Cohance Lifesciences reported a ₹45.19 crore loss in the first quarter, attributing the setback to lower revenue. The company noted growth in certain subsidiaries and API operations, but it was insufficient to offset the decline.
Original headline
Cohance Lifesciences reports ₹45.19 crore loss in Q1 on lower revenue